![Breast cancer: 10 years of drugs to protect against recurrence](https://img.passeportsante.net/1000x526/2016-06-06/i64821-cancer-du-sein-10-ans-de-medicaments-pour-proteger-de-la-recidive.jpg)
June 6, 2016.
The standard protocol after breast cancer is to take hormone therapy for five years to block the risk of recurrence. But many women stop because of the side effects …
Tamoxifen, anti-aromatase: disabling side effects
We understand women who stop their treatment after having fought and conquered breast cancer. The side effects are indeed painful. Tamoxifen, given to premenopausal women, causes the symptoms, which are amplified. Anti-aromatase agents weaken the bones, even causing repeated fractures in some patients.
However, an English study shows that the continuation of these treatments, in spite of the side effects, effectively reduces the risks of recurrence of the cancer. And that the continuation of the treatment over ten years, and not five years, according to the standard protocol, continues to make it possible to decrease the risks of new cancerous tumor.
Anti-aromatases, more and more prescribed
The anti-aromatases are of greatest interest, according to the study, and they are increasingly prescribed. During the experiments, which took place over 10 years, the number of recurrences fell by 34% in the group that had continued to take their treatment for 10 years. instead of 5 years, like the women in the control group …
To read on the same subject: Tamoxifen, its different dosages